John J. Tentler

4.3k citations

79 papers · 3.1k indexed · 1 hit paper · h-index 29

Molecular Biology top 5%
Oncology top 2%
Cancer Research top 5%
Pulmonary and Respiratory Medicine top 10%
Endocrinology, Diabetes and Metabolism top 5%

Co-authors: Todd M. Pitts Aik Choon Tan Sabine Eckhardt Stephen Leong Wells A. Messersmith John J. Arcaroli Colin D. Weekes Antonio Jimeno
Topics: Growth Hormone and Insulin-like Growth Factors (16 papers)Cancer-related Molecular Pathways (13 papers)Hypothalamic control of reproductive hormones (13 papers)
Cited by: Oncology Cancer Research Reproductive Medicine
Journals: Journal of Clinical Oncology PLoS ONE Cancer Research
Partner nations: United States Canada United Kingdom

In The Last Decade

John J. Tentler

77 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patient-derived tumour xenografts as models for oncology drug development

2012 933 citations John J. Tentler, Aik Choon Tan et al. profile →

Peers

Countries citing papers authored by John J. Tentler

Since Specialization

Citations

This map shows the geographic impact of John J. Tentler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Tentler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Tentler more than expected).

Fields of papers citing papers by John J. Tentler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Tentler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Tentler. The network helps show where John J. Tentler may publish in the future.

Co-authorship network of co-authors of John J. Tentler

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Tentler. A scholar is included among the top collaborators of John J. Tentler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Tentler. John J. Tentler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors 2021 ·Molecular Cancer Therapeutics ·Jennifer R. Diamond,Todd M. Pitts,Dana Ungermannova,Christopher G. Nasveschuk,Gan Zhang,Andrew J. Phillips,Stacey M. Bagby,(unknown),Betelehem W. Yacob,(unknown),John J. Tentler,(unknown),Sarah J. Hartman,John A. DeMattei,James D. Winkler,Michael K. Wendt,William P. Schiemann,S. Gail Eckhardt,Xuedong Liu,Anthony D. Piscopio	10
2	RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer 2020 ·BMC Cancer ·John J. Tentler,Julie Lang,Anna Capasso,Deog Joong Kim,Ely Benaim,Young Bok Lee,Andrew Eisen,Stacey M. Bagby,Sarah J. Hartman,Betelehem W. Yacob,(unknown),Todd M. Pitts,Roberta Pelanda,S. Gail Eckhardt,Jennifer R. Diamond	21
3	First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer 2019 ·Molecular Cancer Therapeutics ·Anna Capasso,Stacey M. Bagby,(unknown),Naomi Currimjee,Betelehem W. Yacob,(unknown),(unknown),Deog Joong Kim,(unknown),Young Bok Lee,Ely Benaim,(unknown),Sarah J. Hartman,Aik Choon Tan,Jihye Kim,Todd M. Pitts,S. Gail Eckhardt,John J. Tentler,Jennifer R. Diamond	27
4	Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma 2018 ·Molecular Cancer Therapeutics ·(unknown),Katherine A. Minson,John J. Tentler,(unknown),Stacey M. Bagby,William A. Robinson,(unknown),Tal Burstyn‐Cohen,S. Gail Eckhardt,Xiaodong Wang,Stephen V. Frye,H. Shelton Earp,Deborah DeRyckere,Douglas K. Graham	26
5	Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924) 2016 ·Investigational New Drugs ·Kit Man Wong,(unknown),Heather M. Selby,Aik Choon Tan,Todd M. Pitts,Stacey M. Bagby,Anna Spreafico,(unknown),Stephen J. Blakemore,Peter F. Smith,Alice McDonald,Allison Berger,John J. Tentler,Sabine Eckhardt	16
6	p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer 2015 ·Molecular Cancer Therapeutics ·John J. Tentler,(unknown),Aik Choon Tan,(unknown),Todd M. Pitts,Magdalena J. Glogowska,Peter Kabos,Carol A. Sartorius,Kelly D. Sullivan,Joaquı́n M. Espinosa,S. Gail Eckhardt,Jennifer R. Diamond	39
7	Antitumor Activity of the MEK Inhibitor TAK-733 against Melanoma Cell Lines and Patient-Derived Tumor Explants 2014 ·Molecular Cancer Therapeutics ·(unknown),John J. Tentler,Aik Choon Tan,Heather M. Selby,(unknown),(unknown),S. Lindsey Davis,(unknown),Todd M. Pitts,(unknown),(unknown),Shawn M. O’Connell,Patrick W. Vincent,S. Gail Eckhardt	21
8	Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer 2013 ·Clinical Cancer Research ·Anna Spreafico,John J. Tentler,Todd M. Pitts,Aik Choon Tan,Mark A. Gregory,John J. Arcaroli,(unknown),Martine C. McManus,Ryan J. Hansen,Jihye Kim,(unknown),Heather M. Selby,(unknown),(unknown),Daniel L. Gustafson,James DeGregori,Wells A. Messersmith,Robert A. Winn,Sabine Eckhardt	58
9	Overcoming IGF1R/IR Resistance through Inhibition of MEK Signaling in Colorectal Cancer Models 2013 ·Clinical Cancer Research ·(unknown),Todd M. Pitts,(unknown),Gillian N. Kulikowski,Aik Choon Tan,Martine C. McManus,Anna Spreafico,(unknown),Heather M. Selby,John J. Tentler,Sabine Eckhardt,Stephen Leong	46
10	CtBP1 Is Expressed in Melanoma and Represses the Transcription of p16INK4a and Brca1 2013 ·Journal of Investigative Dermatology ·Hui Deng,Jing Liu,Yu Deng,Gangwen Han,Yiqun G. Shellman,Steven E. Robinson,John J. Tentler,William A. Robinson,David A. Norris,Xiao‐Jing Wang,Qinghong Zhang	28
11	Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models 2012 ·Clinical Cancer Research ·Jennifer R. Diamond,S. Gail Eckhardt,Aik Choon Tan,(unknown),Heather M. Selby,(unknown),(unknown),Marileila Varella‐Garcia,Todd M. Pitts,Mark R. Bray,Graham C. Fletcher,John J. Tentler	39
12	Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development 2010 ·Clinical Cancer Research ·Todd M. Pitts,Aik Choon Tan,Gillian N. Kulikowski,John J. Tentler,Amy Brown,(unknown),Stephen Leong,Christopher D. Coldren,Fred R. Hirsch,Marileila Varella‐Garcia,Christopher Korch,Sabine Eckhardt	56
13	Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K- ras –Mutated Colorectal Cancer 2010 ·Molecular Cancer Therapeutics ·John J. Tentler,Sujatha Nallapareddy,Aik Choon Tan,Anna Spreafico,Todd M. Pitts,Maria Pia Morelli,Heather M. Selby,(unknown),(unknown),Gillian N. Kulikowski,Stephen Leong,John J. Arcaroli,Wells A. Messersmith,Sabine Eckhardt	63
14	The Epithelial-Specific ETS Transcription Factor ESX/ESE-1/Elf-3 Modulates Breast Cancer-Associated Gene Expression 2003 ·DNA and Cell Biology ·(unknown),John J. Tentler,(unknown),Scott E. Diamond,Arthur Gutierrez‐Hartmann	43
15	Ethanol, growth hormone and testosterone in peripubertal rats 1997 ·Journal of Endocrinology ·John J. Tentler,Nancy LaPaglia,J. Steiner,Darren W. Williams,M Castelli,Mark R. Kelley,Nicholas Emanuele,Mary Ann Emanuele	38
16	Coupled reverse transcription-polymerase chain reaction (RT-PCR) technique is comparative, quantitative, and rapid: Uses in alcohol research involving low abundance mRNA species such as hypothalamic LHRH and GRF 1993 ·Alcohol ·Mark R. Kelley,(unknown),John J. Tentler,Nicholas Emanuele,Sarah E. Blutt,Mary Ann Emanuele	50
17	In vivo effects of acute EtOH on rat α and β luteinizing hormone gene expression 1991 ·Alcohol ·Mary Ann Emanuele,John J. Tentler,Nicholas Emanuele,Mark R. Kelley	28
18	The Effect of in Vitro Ethanol Exposure on Lhrh Release from Perifused Rat Hypothalami 1990 ·Endocrine Research ·Mary Ann Emanuele,John J. Tentler,Domenic J. Reda,Lidia Kirsteins,Nicholas Emanuele,Ann M. Lawrence	15
19	In Vitro Effect of Ethanol Exposure on Basal and GnRH-Stimulated LH Secretion from Pituitary Cells 1989 ·Endocrine Research ·Mary Ann Emanuele,John J. Tentler,Nicholas Emanuele,Domenic J. Reda,Lidia Kirsteins,A. M. Lawrence	13
20	Extrahypothalamic brain prolactin: characterization and evidence for independence from pituitary prolactin 1987 ·Brain Research ·Nicholas Emanuele,(unknown),(unknown),John J. Tentler,Thad C. Hagen,Charles T. Beer,Donald R. Martinson,Peter W. Gout,Lidia Kirsteins,A M Lawrence	24

About John J. Tentler

John J. Tentler is a scholar working on Reproductive Medicine, Oncology and Endocrinology, Diabetes and Metabolism, having authored 79 papers that have together received 3.1k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (16 papers), Cancer-related Molecular Pathways (13 papers) and Hypothalamic control of reproductive hormones (13 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (608 citations) and Reproductive Medicine (238 citations). John J. Tentler has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Todd M. Pitts, Aik Choon Tan, Sabine Eckhardt, Stephen Leong, Wells A. Messersmith, John J. Arcaroli, Colin D. Weekes, Antonio Jimeno, Mark R. Kelley and Nicholas Emanuele. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact